Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A comprehensive pancancer analysis reveals the potential value of RAR-related orphan receptor C (RORC) for cancer immunotherapy

15 Sept 2022

Abstract excerpt

Background: RAR-related orphan receptor C (RORC) plays an important role in autoimmune responses and inflammation. However, its function in cancer immunity is still unclear. Its potential value in cancer immunotherapy (CIT) needs to be further studied. Methods: Expression and clinical data for 33 cancers were obtained from UCSC-Xena. The correlation between RORC expression and clinical parameters was analyzed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Drug Transport and Resistance Mechanisms
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36186454
DOI: 10.3389/fgene.2022.969476

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A comprehensive pancancer analysis reveals the potential value of RAR-related orphan receptor C (RORC) for cancer immunotherapyPMID 36186454Read ↗

Decreased RORC expression and downstream signaling in HTLV-1-associated Adult T-cell Lymphoma/Leukemia uncovers an antiproliferative IL17 link: a potential target for immunotherapy?Semantic proximity Read ↗

PTPRC as a pan-cancer biomarker: Prognostic significance and immune microenvironment interactionsSemantic proximity Read ↗

<i>KALRN</i> Mutations Promote Anti-tumor Immunity and Immunotherapy Response in CancerSemantic proximity Read ↗

RREB1 could act as an immunological and prognostic biomarker: From comprehensive analysis to osteosarcoma validation.Semantic proximity Read ↗

The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human CancersSemantic proximity Read ↗

Systematic pan-cancer analysis reveals XCR1 as a Prognostic and Immunological BiomarkerSemantic proximity Read ↗

Targeting ROR1 identifies new treatment strategies in hematological cancersSemantic proximity Read ↗

KALRN mutations promote antitumor immunity and immunotherapy response in cancer.Semantic proximity Read ↗

Integrated Pan-Cancer Profiling of RAC1: Prognostic, Immunomodulatory, and Therapeutic Resistance InsightsSemantic proximity Read ↗

Oncogenic Potential of Replication Factor C Subunit 4: Correlations with Tumor Progression and Assessment of Potential InhibitorsSemantic proximity Read ↗

NFAT primes the human RORC locus for RORγt expression in CD4+ T cellsSemantic proximity Read ↗

Integrative and Comprehensive Pancancer Analysis of Regulator of Chromatin Condensation 1 (RCC1)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.